ANTHEM BIOSCIENCES Q2 FY27 ; NET PROFIT UP 22% AT ₹211 CR (YOY), UP 76% (QOQ)

REVENUE UP 8% AT ₹594 CR (YOY), UP 42% (QOQ) EBITDA UP 24% AT ₹271 CR (YOY), UP 80% (QOQ) MARGINS AT 45.7% VS 39.7% (YOY), 36.0% (QOQ)

ANTHEM BIOSCIENCES LTD